Wellgistics Health, Inc.
WGRX
$3.05
$0.196.64%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -85.64% | -86.54% | -46.90% | 17,407.64% | 6,347.12% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -85.64% | -86.54% | -46.90% | 17,407.64% | 6,347.12% |
| Cost of Revenue | -86.34% | -14.65% | -46.01% | 15,367.30% | -- |
| Gross Profit | -75.43% | -729.12% | -55.68% | 19,553.85% | -- |
| SG&A Expenses | -81.34% | -4.82% | 1,622.26% | 812.22% | 39,045.49% |
| Depreciation & Amortization | -55.56% | 24.01% | 71.76% | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -82.05% | -10.46% | 365.87% | 2,052.07% | 52,796.99% |
| Operating Income | 80.81% | -241.50% | -1,708.13% | -859.93% | -39,183.71% |
| Income Before Tax | 76.13% | -542.99% | -1,738.15% | -1,061.85% | -38,926.35% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 76.13% | -542.99% | -1,738.15% | -1,061.85% | -38,926.35% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 76.13% | -542.99% | -1,738.15% | -1,061.85% | -38,926.35% |
| EBIT | 80.81% | -241.50% | -1,708.13% | -859.93% | -39,183.71% |
| EBITDA | 81.47% | -286.90% | -2,283.00% | -729.09% | -- |
| EPS Basic | 88.15% | -224.81% | -1,096.19% | -763.19% | -33,520.56% |
| Normalized Basic EPS | 87.78% | -59.35% | -1,048.98% | -763.32% | -33,498.97% |
| EPS Diluted | 88.15% | -224.81% | -1,096.19% | -763.19% | -33,520.56% |
| Normalized Diluted EPS | 87.78% | -59.35% | -1,048.98% | -763.32% | -33,498.97% |
| Average Basic Shares Outstanding | 101.52% | 97.95% | 53.66% | 34.58% | 16.09% |
| Average Diluted Shares Outstanding | 101.52% | 97.95% | 53.66% | 34.58% | 16.09% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |